A Structural and Dynamic Perspective on Xenobiotic Metabolism by Cytochrome P450

Abstract

Xenobiotic detoxification is the biotransformation of exogenous compounds entering the human body through enzymatic catalysis in order to assist their eventual elimination. In the past, static active-site models that mainly focus on substrate binding and oxidation chemistry have been employed to understand the xenobiotic functionality of CYP450s. However, modern computational approaches in the field of enzymology have changed this perspective, which show that the P450 machinery utilizes significant structural flexibility and electrostatic control to achieve its function. This review aims to unify these developments into an integrated mechanistic framework that encompasses substrate orientation, conformational gating, catalytic-site organization, transient water-channel assembly, and modulation of the electronic-structure landscape via classical electrostatic and steric confinement. Special focus has been given on how flexible loops/helices, gating residues, transient access channels, along with second-shell residues, dictate xenobiotic accommodation, regio-, stereo-, and chemoselectivity across various members of the CYP450 superfamily.

1. Introduction

Human Cytochromes P450 (CYP450) are crucial in the metabolism of several xenobiotics and are believed to be the first line of defense for the organism against several chemical entities, ranging from life-saving pharmaceuticals to environmental pollutants. − In fact, human CYP450s are supposed to catalyze the biotransformation of approximately 75–90% of all clinically utilized drugs. − While the human genome encodes 57 distinct CYP isoforms, a highly specialized group of P450 enzymes, specifically CYP3A4, CYP2D6, CYP2C9, CYP2C19, and CYP1A2, carries the responsibility of metabolizing the vast majority of this pharmacological burden. , This is achieved through a highly regulated catalytic cycle, initiated when the xenobiotic compound enters the catalytic site of CYP450. The core of this catalytic machinery is a heme-porphyrin moiety that forms an oxo-ferryl porphyrin radical cation commonly designated as compound I, which is further responsible for the oxidation of these xenobiotic molecules. − A thorough discussion of the mechanism of such oxidations by CYP450 has been extensively studied and is discussed in several excellent reviews and monographs. − ,− However, the efficiency of xenobiotic metabolism by CYP450s is not limited only to the reactivity pattern of the heme-porphyrin but is also regulated by several other factors. For example, CYP450s have the ability to render lipophilicity of the substrates into more hydrophilic forms for excretion; they can, at the same time, trigger lethal bioactivation. − Due to this, highly reactive electrophilic intermediates are generated, causing mechanism-based inactivation (MBI) or severe hepatotoxicity. ,− Another such example is the highly promiscuous isoforms like human CYP3A4, which undergo unwanted inhibition, which then gives rise to severely adverse drug–drug interactions (DDIs). This clinical vulnerability came to light during the COVID pandemic at the onset of this decade, particularly in the case of the SARS-CoV-2 combination antiviral Paxlovid. It was observed that the dependency of this antiviral compound on ritonavir, which is a potent inhibitor of CYP3A4, directly triggered life-threatening tacrolimus accumulation and renal failure in immunosuppressed transplant patients. Therefore, for modern predictive toxicology and the safe design of future therapeutics, it becomes vital that the precise rules of engagement between these CYP enzymes and foreign molecules are deeply understood.

Historically, the detoxification of xenobiotics by human CYP450s has been viewed through a static, reductionist perspective, in which geometric snapshots of structures obtained via X-ray diffraction have been extensively used to make mechanistic claims about how these molecular machines work. The “lock-and-key” perspective explains catalysis solely on the basis of first-shell geometry and preorganized rigidity. Static crystallographic snapshots, though foundational, often capture dormant, ligand-free apo states or artificially constrained holo states that fail to capture the dynamics of substrate entry/exit, including active-site plasticity. However, with the rapid development of computational structural biology, supported by microsecond-scale MD simulations and hybrid quantum mechanics/molecular mechanics (QM/MM) calculations, this old notion has been fundamentally shattered. , These powerful modern approaches enable the discovery of transient access channels and dynamically gated systems that are invisible to X-ray crystallography. Coupled with QM/MM, which allows for the precise elucidation of the reaction pathway, we now understand that human CYP450s function as highly adaptable, reconfigurable soft-robot nanomachines.

Despite these advances, the current literature offers a very fragmented mechanistic understanding of xenobiotic detoxification within the cytochrome P450 systems. Existing studies and reviews have independently explored substrate access pathways, conformational dynamics, catalytic water networks, electrostatic regulation and quantum-mechanical reaction mechanisms, often treating these phenomena as isolated layers of catalysis. ,,− Yet, xenobiotic metabolism is fundamentally a multiscale process where protein dynamics, solvent networks and quantum mechanical events constantly influence one another throughout the catalytic cycle. Consequently, we still lack a unified biophysical framework that seamlessly connects these overlapping mechanistic levels into a single continuous description of cytochrome P450 function.

To address the fragmented treatment of cytochrome P450 catalysis in the current literature, this review is organized around four interconnected sections that collectively govern xenobiotic biotransformation. In the first section, we examine how flexible loops and open channels enable the molecule to enter the buried active site. Second, we examine how the shape of the active site locks the molecule into place to dictate where and how the chemical reaction takes place. The third section focuses on the hidden role of internal water architecture in governing reactivity, particularly in proton delivery and proton-coupled electron transfer processes. Finally, we explain how the local electric fields lower the energy barriers to kickstart the reaction.

Together, these sections aim to unify the aforementioned phenomena into a cohesive framework in which catalytic selectivity and reactivity emerge not as isolated chemical events, but from the coordinated interplay of structural dynamics, solvent organization, substrate confinement and quantum-mechanical regulation within the cytochrome P450 catalytic environment.

2. Insights into Xenobiotic Detoxification

A highly coordinated series of interrelated mechanistic events, ranging from substrate recognition to electronic state control of catalytic reactivity, gives rise to xenobiotic detoxification within cytochrome P450 systems. These reactions are not separate chemical transformations but rather result from the constant interplay among solvent organization, substrate entrapment within the active site, conformational plasticity, and electrostatic modulation in the catalytic environment. In the sections that follow, we look at how these connected mechanistic aspects work together to control P450 activity, proton-transfer kinetics, substrate availability and catalytic selectivity during cytochrome P450-mediated metabolism.

2.1. Dynamic Gating and Structural Reorganization

Substrate recognition in cytochrome P450 enzymes is not governed by a rigid preformed catalytic cavity. Instead, xenobiotic entry initiates a highly adaptive sequence of conformational rearrangements that dynamically reshape the catalytic landscape. As the xenobiotic molecule moves across the access channels and enters the catalytic pocket of the enzyme, the human cytochrome P450 enzymes completely defy the classical “lock-and-key” paradigm. , In other words, they operate as mechanosensitive nanomachines. As the xenobiotic approaches and binds itself to the catalytic core, a massive, allosteric structural reorganization is triggered across the entire macromolecule. In order to accommodate ligands of varying sizes, the highly promiscuous isoforms, such as CYP3A4, are capable of expanding their internal active site volume by over 80% (Figure ). This substantial structural modulation is achieved via coordinated displacement of the F-G region, the C-terminal loop and the I-helix. Rather than selectively filtering substrates to fit a preexisting static cavity, the enzyme dynamically reconstructs its internal architecture to trap and confine the incoming xenobiotic.

1.

Homotropic cooperativity and extreme volume modulation in the CYP3A4 active site. (a–c) Representative images showing the dynamic plasticity of the 1.4 K/β loop and its impact on active site volume when bound to two carbamazepine (CBZ) molecules (marine blue). The substantial volume changes are highlighted by the distances between residue 369 and F304 on the I-helix (blue dashed line). (a) Wild-type enzyme exhibiting standard pocket distance of ∼11.6 Å. (b) I369F mutation leads to restriction in the active site (∼8.0 Å) and exhibits a forced kink (black arrow). (c) The A370V mutation induces substantial volume increase (∼13.0 Å), making way for two molecules of CBZ. (d) Zoomed-in view of the active site of the A370V mutant. The increased active site size allows the second CBZ molecule (yellow) to act as a rigid physical wedge, mechanically trapping the first CBZ molecule (blue) into a productive catalytic pose. Figure adapted from ref . Copyright 2015 American Chemical Society.

However, active site expansion alone does not guarantee productive substrate entry. Access to the buried catalytic site is further regulated through transient gating motions. As the xenobiotic resides at the enzyme’s surface, it triggers a massive induced-fit transition, promoting large-scale displacements of highly flexible motifs such as the F–F′ loop, into a sharply upward, open conformation (Figure a). This major structural overhaul leads to the repositioning of the steric barriers, actively displacing superficial side-chains (like R212 and L216) to permit entry. However, after the eventual confinement of the xenobiotic within the active site, the enzyme immediately clamps the F–F′ loop downward into a closed conformation (Figure ). Following substrate entrapment within the active site, the loop rapidly recloses, sealing the catalytic cavity and kinetically stabilizing the bound xenobiotic.

2.

6′-7′-Dihydroxybergamottin (DHB) binding dynamics and F–F′ loop conformational shift. (a) F–F′ loop in downward orientation, blocking the entry of the substrate (wheat). The same loop in upward orientation (green) after 10 ns of simulation. Notice the away orientation of R212 facilitating substrate ingress. (b) Representative image showing the two key residues R212 and L216 of the loop in downward orientation leading to the blockade of the substrate access channel. (c) The key residues R212 and L216 in upward orientation enabling DHB to access the active site of the enzyme. Adapted with permission under a Creative Commons CC-BY-NC-ND 4.0 from ref . Copyright 2026 Springer Nature.

In highly flexible CYP isoforms, these adaptive movements do more than just make room for a substrate. They actually enable multiple substrates to interact cooperatively within the active site. In extreme cases of adaptive confinement, the expansive internal architecture can accommodate multiple xenobiotics simultaneously, exhibiting homotropic cooperativity. Owing to the intrinsic plasticity of internal structural elements like 1.4 K/β loop, the enzyme allows a secondary substrate to enter the cavity. Rather than binding passively, this secondary molecule acts as a “physical wedge”, utilizing internal crowding to rigidly trap the primary xenobiotic into a highly ideal, productive catalytic pose directly adjacent to the reactive iron-oxo center. These xenobiotic-induced conformational shifts allow the enzyme to execute a dual action. First, it removes the surface barriers to permit entry, and second, it exploits the steric crowding to force the substrate into a thermodynamically trapped, reactive geometry (Figure c–d). While static free-energy calculations struggle to capture the thermodynamics of these massive, macroscopic volume shifts, microsecond-scale simulations coupled with experimentally derived kinetic data validate their functional importance. For instance, the massive volume expansion observed in the A370V mutant in which the cross-pocket distance increases to ∼13.0 Å, is directly correlated with the acceleration observed in the enzyme’s turnover efficiency (k _cat ≈ 4.6 min^–1 compared to the wild-type k _cat ≈ 1.4 min^–1) along with the complete thermodynamic elimination of substrate inhibition. Conversely, the I369F variant restricts the pocket (cross-pocket distance = ∼8.0 Å) and adversely affects substrate inhibition. This demonstrates that active site volume dynamically regulates both catalytic turnover and homotropic cooperativity.

Such profound dynamic gating mechanisms are further demonstrated in the regioselective metabolism of caffeine by human CYP1A2. Recent microsecond MD simulations supplemented with geometry-encoded machine learning algorithms reveal that the enzyme does not simply have a singular active site cavity but rather an elaborate and sophisticated architecture of dynamically interacting subsites, viz., a peripheral “effector” site and a deeply buried “producer” site (Figure a–b). As the xenobiotic moves through the access channel, it is initially captured and stalled at the effector subsite. Here, the entry to the catalytically active producer site is governed by a mechanosensitive phenylalanine gatekeeper (Phe202). The aromatic side chain of this gatekeeper undergoes a 90° rotational flip, thereby allowing the xenobiotic to enter the core (Figure c). Simulation results reveal that the internal active-site channel is exceptionally flat, so the xenobiotic is completely unable to exhibit any face-flipping once it enters the producer site. This structurally locks the substrate in a particular configuration, making it susceptible to efficient attack by the oxo-ferryl center. This study demonstrates that catalytic control in P450 systems is not limited to the immediate heme environment but extends beyond it. The peripheral subsites and aromatic gating residues are responsible for the preorganization of the substrate trajectory before oxidation can take place.

3.

(a) Representative image depicting the producer and effector caffeine binding sites with respect to heme and to the FMN domain of the reductase bound to the P450. (b) Detailed view of the producer and the effector sites. (c) Image showing the dynamics of the Phe202 residue. The aromatic residue flips from frame 102 to frame 103. Caffeine is captured via stacking interaction at frame 103 and 104. At frame 105, caffeine is captured at site B (producer site). Adapted with permission under a Creative Commons CC-BY-NC-ND 4.0 from ref . Copyright 2025 Springer Nature.

The physiological importance of these gating dynamics becomes particularly evident in pharmacogenomic variants that expose these biologically vulnerable dynamic gating. In specific mutant alleles, such as the clinically poor metabolizer CYP2D6*4, the inherent flexibility of the FG and BC loops is severely perturbed (Figure ). Whether mutations shift these loops toward excessive rigidity or uncontrolled flexibility, disruption of the dynamic gating landscape compromises coordinated xenobiotic transport and limits metabolic function. Nevertheless, xenobiotic capture and confinement alone are insufficient to determine the catalytic outcome. Once the xenobiotic is enclosed within the active site, it must undergo precise spatial and energetic organization that selectively exposes its reactive centers directly to the oxidizing heme. The above studies show that cytochrome P450 catalysis depends heavily on how the enzyme binds and positions the substrate, extending far beyond mere gating.

4.

Pharmacogenomic disruption of dynamic gating in human CYP2D6. Structural ensembles (initial and most populated kinetic conformations) of the wild-type (CYP2D6*1) enzyme. The wild-type displays tightly coordinated positioning of its flexible gatekeeping elements such as FG (black), BC (cyan), and AB (pink) loops, establishing an enclosed active site for optimal xenobiotic capture. (Top right) Corresponding ensemble for the clinically poor metabolizer variant, CYP2D6*4. The loop arrangements are disrupted due to which the active site becomes less confined and leads to inefficient capture of the xenobiotic (Bottom). Reproduced with permission under a Creative Commons CC-BY 4.0 from ref . Copyright 2018 PLOS.

2.2. Substrate Positioning and Catalytic Selectivity

Once confined within the catalytic pocket through conformational changes, as discussed in the previous section, the substrate’s chemical fate is governed by its precise spatial positioning relative to the oxidizing iron center. In cytochrome P450 systems, regioselectivity, stereoselectivity, and chemoselectivity arise directly from the enzyme’s ability to stabilize specific, reactive binding poses over others. By controlling how the xenobiotic approaches the highly reactive FeO center, the enzyme effectively determines which bonds participate in catalysis, thereby defining the landscape of possible reaction pathways.

However, assuming that the xenobiotic immediately docks into this perfectly preorganized catalytic pose is not in line with the dynamic reality of P450 enzymes. Crucially, high-resolution solution nuclear magnetic resonance (NMR) investigations experimentally demonstrate that this optimal spatial trajectory is rarely achieved upon initial capture of the xenobiotic. Instead, when the xenobiotic initially binds, it is often trapped in an open, loose conformation that is geometrically incorrect for the required chemical reaction. The enzyme must via allosterically driven mechanical reorientation force the substrate into the correct catalytic pose. In the case of CYP101A1, NMR characterization reveals the substrate is completely in a nonproductive orientation when it is initially trapped in the active site, highlighting a dormant state of the enzyme. This dormancy persists until the redox effector protein is distally docked, which then triggers a massive, global response. This trans-protein mechanotransduction traverses the macromolecule to the entrance of the active site, where a sudden trans–cis isomerization of a highly specific Ile-Pro bond occurs. This serves as a thermodynamic lever, concurrently sealing the active site from the bulk solvent and physically pushing the xenobiotic into its rigid, crystallographically observed catalytic pose.

The ability of the protein environment to dominate over the innate substrate reactivity is particularly evident in the stereoselective metabolism of the chiral proton-pump inhibitor omeprazole by human CYP2C19. It is administered as a racemic mixture of its R- and S-enantiomers, and both show identical C–H bond strengths. Despite this, they are treated differently in the human liver by CYP2C19. The enzyme preferentially hydroxylates the R-omeprazole at the 5-methyl site to produce 5-hydroxyomeprazole, whereas the S-enantiomer undergoes oxidation at the 5′-methoxy position to yield 5′-O-hydroxyesomeprazole.

Molecular dynamics simulations and advanced QM/MM methods reveal that this differential metabolic outcome arises from the distinct nature of the reactant complexes (RCs) within the active site. Owing to the different spatial orientations of the 5-methyl and 5′-methoxy groups, it is paramount that the individual enantiomers adopt distinct binding poses, leading to shifts in the thermodynamic landscape. The optimal catalytic pose is guaranteed by an intricate, water-mediated hydrogen-bond network that connects the substrate to the critical polar residues, specifically N79, N176, D265 and F448. Furthermore, T-shaped π-π interaction between the aromatic moiety of the substrate and the phenyl side chain of F448 lock the substrate in the correct catalytic pose (Figure ). Adhering to the Curtin-Hammett principle, the localized protein environment allows for distinct activation energies based on the relative stabilities of these substrate-binding poses, thereby demonstrating that the atomic architecture of the active site governs enantiomeric clearance.

5.

Local binding environments and hydration profiles of omeprazole enantiomers. Omeprazole, catalytic water molecules and key residues are shown in licorice representation. Heme moiety is highlighted in pink. (a) Stereoselective binding pose of R-omeprazole (pathway ra). (b) Binding pose of S-omeprazole (pathway sb). Probability distribution of the H-bond network and also for the direct interaction between substrate and active side residues for (c) R-omeprazole (d) S-omeprazole. The structural probability distributions for the hydrogen-bond networks were extracted from 50 ns restraint-free production MD simulations, with the entire system solvated using the explicit water model. Reproduced with permission under a Creative Commons CC-BY-NC-ND 4.0 from ref . Copyright 2025 Hirao et al. American Chemical Society.

These findings demonstrate that catalytic selectivity in P450 systems is not dictated solely by the inherent electronic properties of the substrate, but rather by the enzyme’s propensity to dynamically confine and stabilize specific reactive poses within the catalytic core. The ability of the CYP450 machinery to exert absolute control over the substrate’s orientation within the active site is captured in the regio- and enantioselective hydroxylation of arachidonic acid by human CYP2E1.

Despite the inherent conformational flexibility of this long-chain polyunsaturated fatty acid, the enzyme strictly catalyzes the reaction producing 19­(S)-HETE. MD simulations and QM/MM (ONIOM) investigations reveal that this precise selectivity is governed by modulation of the active site volume by the enzyme. Unlike other isoforms that accommodate ligands through volume expansions, the active site of CYP2E1 is highly constrained owing to the unusual conformation of the Ile115 residue. The hydrophobic Ile115 is able to physically curl and capture the aliphatic tail of the substrate, forcibly orienting the ω-1 carbon directly toward the iron-oxo moiety (Figure ). Unbiased simulations prove that this spatial configuration forces the substrate into an S-R conformation, allowing the pro-S hydrogen at the ω-1 position to get attacked. QM/MM calculations further reveal that the energetic barrier for this specific ω-1S pathway is the lowest at 18.6 kcal/mol compared to alternative regiochemical targets such as ω, ω-1R, ω-2R and ω-2S. Crucially, this low activation energy is not the inherent property of this specific C–H bond, rather it is engineered by the active site’s microenvironment. Energy decomposition analysis reveals that a previously unrecognized conserved residue, Ala299, positions its side chain methyl carbon a mere 3.81 Å away from the reaction center. This in turn, provides nonbonded stabilization to this specific transition state. Thus, the CYP nanomachine utilizes van der Waals constraints to steer the chemical outcome to a particular reaction pathway and in turn dictate enantioselectivity.

6.

Representative image showing Ile115 residue forcing the ω-1 carbon of the aliphatic tail of the substrate toward the iron-oxo center dictating the regioselectivity. Reproduced with permission from ref . Copyright 2025 American Chemical Society.

A similar regime is observed in the case of CYP2D6 which catalyzes the cough suppressant dextromethorphan. DFT calculations in the gas phase indicate that the two possible pathways for O-demethylation and aromatic hydroxylation are energetically comparable. However, the behavior is drastically different under physiological conditions. When the researchers ran QM/MM calculations by including the protein environment, they observed a substantial preference for O-demethylation. This clearly highlights the important role of the protein environment in modulating the reaction pathway. The methoxy group is oriented toward the iron-oxo moiety owing to steric and electrostatic constraints put by the CYP2D6 binding pocket whereas the aromatic ring remained shielded from the oxidant. Therefore, we can safely conclude that isolated DFT calculations are insufficient for predicting xenobiotic metabolism without the enzyme’s 3-D landscape.

The aforementioned constraints in the metabolism of substrates like dextromethorphan do not arise from a rigid pocket, but from a highly specific, dual-residue electrostatic relay system. For decades, it has been assumed that the basic nitrogen present in the vast majority of CYP2D6 substrates directly formed a salt bridge with D301 to enable a catalytic pose. However, advanced docking studies combined with mutagenesis have demonstrated that the orientation of the basic xenobiotics follows a rigorous spatial route. The acidic residue E216, situated on the F-helix, recognizes the basic moiety of the incoming xenobiotic by acting as a primary electrostatic recognition site, orienting it toward the upward region of the cavity. The D301 residue, on the other hand, restricts the flexible motion of the B′-C loop, leading to preorganization of the internal gatekeeper, viz, the bulky aromatic residue F120 (Figure ).

7.

(a) Representative image depicting the crystal structure of CYP2D6 with key amino acids shown. Key hydrogen bonds between D301 and main chain amides of V119 and F120 are shown with dotted lines. (b) The predicted binding mode of quinidine in wild-type based on best ranked docking score. Notice the influence of the acidic side chain of E216 in dictating the catalytic pose of the substrate. Reproduced with permission from ref . Copyright 2008 Wiley.

The dominance of this specific E216/D301 electrostatic relay over the intrinsic quantum reactivity is demonstrated in the CYP2D6-catalyzed synthesis of the neurotransmitter serotonin from 5-methoxytryptamine (5-MT). Density Functional Theory (DFT) calculations reveal a striking chemical paradox. The neutral, unprotonated form of 5-MT actually exhibits a lower intrinsic energy barrier for the initial hydrogen atom transfer (HAT) than its protonated counterpart. Despite this, the enzyme strictly metabolizes the protonated species (5-MTH+) under physiological conditions. This physiological preference is dictated entirely by the necessity for spatial control. The highly polar NH₃ ⁺ tail of 5-MTH+ functions as a chief electrostatic anchor, interacting strongly with the negatively charged side chains of Glu316 and Asp301 residues within the active site. This strong salt-bridge interaction locks the substrate into a rigid, upright conformation, orienting the target methoxy group toward the Compound I oxidant while physically shielding the highly susceptible indole ring from undesired competitive hydroxylation (Figure a). Moreover, it was observed that if the unprotonated species (5-MT) enters the pocket, the free amino tail of the molecule faces the heme oxo group, owing to the lack of the strong electrostatic interaction from the negatively charged residues which in turn leads to nonproductive inhibition (Figure b–c). Thus, the CYP450 macromolecule will actively sacrifice quantum reactivity in exchange for absolute spatial and regiochemical control, proving that optimal catalysis is defined by macromolecular orientation, not just isolated transition state barriers.

8.

(a) Productive, regioselective conformation: The positively charged −NH₃ ⁺ tail acts as an electrostatic anchor, forming a strong salt-bridge interactions with Glu216 and Asp301. This anchoring forces the molecule into a rigid orientation that presents the target methoxy group directly to the heme oxo-ferryl center while shielding the indole ring from off-target hydroxylation. (b) Nonproductive, inhibitory geometry: Although the neutral form has a lower intrinsic quantum activation barrier for hydrogen atom transfer, it lacks the electrostatic charge required to interaction with Glu216/Asp301 residues. Without this tether, the free amino group protrudes toward the heme iron, thereby locking the substrate in a catalytically inactive pose. (c) Similar conformation as in (a), however, the absence of the charged tail in 5-MT causes diminished electrostatic interaction with the Glu216/Asp301 residues, forcing the substrate into an inhibitory geometry similar to (b). Reproduced with permission from ref . Copyright 2010 American Chemical Society.

More importantly, the regulatory principles governing xenobiotic positioning are not strictly reserved for clinical pharmaceuticals. They equally dictate the biotransformation of complex dietary and environmental toxicants. This is elegantly demonstrated in the mechanism-based inactivation (MBI) of the already discussed human CYP3A4 by 6′,7′-dihydroxybergamottin (DHB), a naturally occurring furanocoumarin found in grapefruit and a potent environmental xenobiotic. In the crystal structure, 6′,7′-dihydroxybergamottin (DHB) adopts a deeply anchored conformation stabilized by hydrogen bonding and π–π interactions with the heme porphyrin. However, this pose is not catalytically optimum as in this orientation, the reactive furan double bond is positioned ∼6.3 Å from the iron-oxo center (Figure a).

9.

(a) Crystal structure of CYP3A4 (PDB ID: 6OOB) showing the binding pose of DHB with the distance between iron of heme and C5 atom of DHB equal to 6.3 Å, which is not catalytically optimum. (b) Representative snapshot from MD simulation depicting the catalytically active binding orientation of DHB in Cpd I state. Notice the Fe–C5 distance reduced to 4.7 Å from 6.3 Å. (c) The transition state for the C5 attack (2a*) exhibits an ideal attack angle, resulting in lower energy barrier (ΔG^‡ = 9.0 kcal/mol) and leads to the formation of γ-ketoenal. (d) Transition state for the C4 epoxidation pathway (2b*) which is a less optimal geometry, exhibiting higher activation energy (ΔG^‡ = 25.0 kcal/mol) making this pathway unfavorable. Comparative thermodynamic analyses reveal a free energy difference (ΔG) of >5 kcal/mol favoring the γ-ketoenal product over the epoxide conformation, proving that C5 attack is both kinetically and thermodynamically dictated by the enzyme. Adapted with permission from ref . Copyright 2025 American Chemical Society.

For chemical transformation, this environmental toxicant must dynamically explore the catalytic space and adopt a viable pose. MD simulations reveal that DHB is highly prone to continuous rotational and translational fluctuations and indeed exhibits reactive conformations. QM/MM study of this reactive conformation demonstrates that the C5 position of the furan ring is more readily attacked by Cpd I, requiring an exceptionally low activation free energy barrier (ΔG^‡) of just 9.0 kcal/mol. In stark contrast, the alternative C4 epoxidation pathway exhibits a relatively massive 25.0 kcal/mol barrier (Figure ). Consequently, the enzyme actively drives the formation of the kinetically favorable γ-ketoenal intermediate over a conventional epoxide. Furthermore, comparative thermodynamic free energy calculations mathematically prove that the resulting γ-ketoenal conformation is over 5 kcal/mol more stable than the corresponding epoxide intermediate. This substantial thermodynamic difference dictates that even if an epoxide were transiently formed, it would rapidly overcome an internal barrier of 13.7 kcal/mol to rearrange into the highly stable γ-ketoenal. This ultimately stable intermediate subsequently restructures the active site and covalently renders the CYP3A4 inactive.

The ability of CYP3A4 to control the binding and lifetime of the xenobiotic within the active site extends far beyond rotational trapping mechanisms as seen in the previous case. The highly promiscuous CYP3A4 dynamically reshapes the free-energy landscape of the active site. Consequently, the xenobiotic molecule can exhibit multiple reactive poses within the catalytic core. This is demonstrated in a study by Fu et al., wherein the allosteric metabolism of the xenobiotic midazolam is shown by CYP3A4. Using 150 ns well-tempered metadynamics (WT-MTD) simulations, Fu and coworkers have shown the active site to possess multiple distinct substrate binding basins termed as poses A, B and C, which in turn dictates the ultimate ratio of regioselective hydroxylations (10-OH versus 4-OH). The xenobiotic transitions between these different poses due to the π-π stacking and steric interactions provided by a single flexible B–C loop residue, Phe108. The aromatic phenyl side chain of Phe108 forms π-π interactions that preferentially locks into the substrate, serving as an anchor that stabilizes the reactive complex in the active site. Moreover, the enzymatic machinery utilizes this specific stacking interaction to shift the xenobiotic’s orientation from pose B to C (Figure a). Disruption of this aromatic contact, such as in the in-silico F108A or F108M mutation, deletes the critical π-π layout and deforms the WT-MTD free energy landscapes (Figure b–c). This adversely affects the enzyme’s ability to perform the geometric flip on the substrate and consequently the regioselective outcome is permanently altered.

10.

Active site geometry of the substrate in pose C in (a) Wild type-CYP3A4, (b) F108A mutant and (c) F108M mutant. In wild-type, the π-π interaction between substrate and F108 keeps the substrate locked in the optimal orientation for regioselective outcome. In the two mutants, due to the mutation, the substrate changes its orientation and regioselective control is also lost. Reproduced with permission from ref . Copyright 2024 Royal Society of Chemistry.

These examples convey that catalytic outcomes in P450 systems are a direct consequence of the three-dimensional configuration of the xenobiotic within the active site. Once a reactive geometry is achieved and the substrate is locked into a productive pose, this static preorganization cannot alone trigger the oxidation process. Nevertheless, optimal substrate alignment does not, by itself, ensure catalysis. Modern studies indicate that reactivity in these systems depends on the dynamic organization of internal solvent networks. These water molecules govern proton transfer, active-site hydration, and electronic communication within the catalytic cavity. We will discuss these effects in the follow-up section.

2.3. Water Architecture as the Hidden Determinant of Reactivity

Classical models of enzymatic catalysis often assume that for efficient oxidation of the xenobiotic, it is paramount for the substrate to be in the correct geometric position, such that the site of reaction lies close to the reactive oxidant. − However, this assumption is challenged by the paradoxical reactivities of highly homologous isozymes such as CYP1A1 and CYP1A2. Despite sharing near-identical active-site architectures, these molecular machines exhibit drastically divergent reactivities toward identical xenobiotics such as the bulky inhibitor α-naphthoflavone (ANF). Structural analyses confirm that both isozymes perfectly trap ANF in the exact same configuration, locking it via identical aromatic π-π stacking interactions while positioning the reactive carbon approximately 10 Å away from the reactive oxo-ferryl moiety.

While CYP1A1 efficiently executes the epoxidation, CYP1A2 remains almost catalytically inert. This profound discrepancy cannot be solved by first-shell geometric parameters. Instead, the answer lies in the dynamic construction of second-shell solvent wires. In the active enzyme, specific internal gating residues (the N222-D320 pair) remain open, allowing the spontaneous formation of a highly ordered, continuous water aqueduct that bridges the ∼10 Å gap between the oxidant and the substrate (Figure a). This solvent wire not only enables distant epoxidation but also acts as an electrical conduit, allowing for a sequential, proton-coupled electron transfer (PCET) relay. Conversely, in the inactive isozyme, the distal F-helix initiates a minor allosteric perturbation, applying a rigid steric “kick”, leading to the permanent collapse of the equivalent gate (T223-D320) into a locked hydrogen bond (Figure ). Thus, first-shell geometric organization alone is insufficient if the second-shell water architecture is devoid of functionality. In this regard, the solvent wire emerges not as a mere structural refinement, but as the active, information-bearing network that transmits the oxidative strike.

11.

(a) Large gap between the side chain of gating pair Asn222-Asp320 allows water molecules to form an ordered water aqueduct, connecting the oxo with the site of epoxidation in CYP1A1. (b) The corresponding gating pair (Thr223-Asp320) in CYP1A2 forms a stable hydrogen bond due to which water ingress into the active site is blocked leading to negligible activity of this isozyme. Notice the ∼10 Å distance between the oxo of Cpd I and the site of epoxidation. Allosteric effect from the F-helix giving rise to a (c) weak steric kick from Leu252 to Asn222, which is not strong enough to lock the gate in CYP1A1, and (d) strong steric kick from bulky Phe256 to Thr223 that forces the water gate to close in CYP1A2. Reproduced with permission from ref . Copyright 2026 American Chemical Society.

Importantly, the assembly of this functional, ordered water channel is not an innate property of the enzyme itself; rather, it is strictly governed by the dynamic conformational fluctuations of the nanomachine itself. Recent microsecond-scale, explicit-solvent molecular dynamics investigations of human CYPs (1A2, 2D6 and 3A4) prove that structural flexibility is an absolute prerequisite for active site hydration. In the case of CYP1A2, there is no formation of an ordered water channel if the enzyme is restrained to its static crystallographic coordinates. This is because the catalytic site is deeply buried and remains isolated, so the enzyme is incapable of forming a contiguous hydrogen-bonded network to exchange water with the bulk exterior. Upon granting the enzyme its full unrestrained conformational plasticity, it undergoes a massive 180% volume expansion (expanding from 500 ų to over 1400 ų) (Figure a). This extreme structural modification dynamically opens transient access channels as a consequence of which substantial water ingress takes place (Figure b). In other words, the structural flexibility of the enzyme does not merely govern xenobiotic capture and its eventual confinement within the active site, it actively gives rise to the aqueous machinery required for the ultimate chemical execution.

12.

(a) Probability distribution of the active site pocket volume across progressive states of atomistic flexibility. The volume is around 500 ų for the restrained (static) structure whereas volume increases to ∼1400 ų for the fully unrestrained system. (b) Corresponding probability distribution showing the water population. Smaller water population for the restrained (static) CYP1A2 with substantial water population for the fully unrestrained CYP1A2 system. The above distribution data was extracted from 1.25 μs explicit simulation trajectory. Adapted with permission under a Creative Commons CC-BY 4.0 from ref . Copyright 2024 MDPI.

Since this water network is so chemically potent, the enzyme must tightly regulate the timing of its assembly. However, the subsequent generation of compound I (Cpd I) oxidant strictly requires two protons. Therefore, the enzyme must feed the catalytic pocket with precisely timed water molecules exactly at the moment of electron delivery.

This astute synchronization is obtained through a trans-protein mechanotransduction. In CYP3A4, the proximal water aqueduct is initially locked tight by a massive salt-bridge between the heme’s propionate-7 side chain and an arginine residue (R375), reinforced by a serine gatekeeper (S437). , Upon eventual docking of the cytochrome P450 reductase (CPR) onto the proximal face, certain frontal residues of the CPR domain (M490) directly collide with the S437 gatekeeper. This allosteric disturbance induces displacement of the arginine residue from the heme propionate (Figure ). This substantial perturbation of the salt-bridge interaction is labeled as the “Open Sesame” event during which the active site is flooded with perfectly positioned water molecules. Beyond proton delivery, these highly ordered water networks so formed can also participate directly in the catalytic transformation itself. Hydration is therefore a strictly timed, allosterically regulated thermodynamic switch using which the enzyme connects the external macromolecular docking to internal solvent assembly, all in order to ensure protons and electrons arrive in flawless synchronization.

13.

Gating mechanism and aqueduct formation in the CYP-CPR complex. (a) Image representing the closed gate state where S437 stabilizes the salt-bridge network through hydrogen bonding. (b) Representative image showing CPR-induced gating where the M490 residue of the FMN domain shifts S437 and R375 downward leading to the opening of the gate. (c) Image depicting the ingress of water molecules through the newly opened aqueduct, facilitated by the outward tilting of E308. Part (a) adapted with permission from ref . Copyright 2021 Elsevier. Part (b) and (c) adapted from ref . Copyright 2010 American Chemical Society.

Once this ordered aqueduct is established, the water molecules go beyond their canonical role as mere proton wires. Not only do these ordered water residues evolve into active chemical reagents, but they also actively determine the fundamental chemical identity of the active oxidant itself. This unique characteristic has helped in the resolution of the long-standing mechanistic debate regarding the C–C bond cleavage reactions catalyzed by steroid-metabolizing isoforms, such as human P450 17A1 and 51A1. Earlier hybrid QM/MM and long-scale MD simulations rigorously highlighted this enzymatic conundrum in human P450 51A1, demonstrating the challenge of determining whether the elusive C–C bond cleavage is initiated by the unhydrated aldehyde or the hydrated gem-diol intermediate. Building upon this foundational dilemma, recent microsecond MD simulations combined with hybrid QM/MM calculations have shown that the integrity of the proton channel controls whether the Fe­(III)-peroxo species or Compound I serve as the chief oxidant. In CYP450 17A1, the Fe­(III)-peroxo species is physically incapable of mediating the C17–C20 cleavage of 17α-hydroxypregnenolone. Instead, a highly ordered water channel is essentially required to facilitate the transfer of two protons, enabling the conversion of the peroxo species into the highly reactive Cpd I, which in turn initiates the C–C fission via hydrogen abstraction from the C17-OH moiety (Figure a). Conversely, the promiscuous P450 51A1 nanomachine modulates oxidant selection through the hydration state of its substrate. When the aldehyde form of the substrate binds, it physically disrupts the proton channel, hindering the formation of Cpd I but simultaneously enabling an efficient, direct nucleophilic attack by the Fe­(III)-peroxo species. However, when the gem-diol form of the substrate is present in the active site, the vital solvent wire remains intact, efficiently driving the generation of Cpd I to mediate the C–C cleavage (Figure b). Thus, the CYP450 nanomachine leverages transient water networks as dynamic thermodynamic switches, enabling selection between competing high-valent iron-oxo oxidants through subnanometer substrate positioning.

14.

Dynamic solvent architecture and proton-channel regulation dictate oxidant selection in CYP450s. (a) In human P450 17A1, a water channel is engineered connecting the peroxo moiety with the bulk solvent that drive successive protonation and the eventual formation of Cpd I, which initiates cleavage via H-abstraction from the C17-OH. (b) In human P450 51A1, the primary oxidant is decided entirely by the hydration state of the substrate. The aldehyde form (left) physically traps H314, destroying the water channel and forcing a direct nucleophilic attack by the peroxo species. Conversely, the gem-diol form (right) actively maintains the vital proton wire, successfully forms the Cpd I intermediate leading to the efficient C–C bond cleavage. Adapted from ref . Copyright 2025 American Chemical Society.

The catalytic effect of the water architecture goes beyond proton-transfer chemistry. As previously observed during the stereoselective confinement of omeprazole, specific water molecules construct localized H-bond bridges that directly determine the activation barrier (ΔG^‡) of distinct reaction pathways. It was observed that if the free-energy corrections from these explicit water networks are removed from the computational models, all predictive power regarding chemoselectivity collapses.

Collectively, these studies demonstrate that solvent architecture in CYP450s functions not only as a passive hydration shell, but also as a dynamically regulated catalytic framework that controls proton transfer, substrate activation and long-range electronic communication within the active site. In other words, true catalytic reactivity emerges from a synergistic effect between solvent organization and the evolving electrostatic environment of the enzyme.

2.4. Electrostatic Control of Reactivity in Cytochrome P450 Systems

The preceding sections demonstrate that the catalytic outcome in cytochrome P450 systems arise from a coordinated structural dynamics, substrate confinement and solvent organization. Yet, even these interconnected mechanistic factors do not completely explain how the enzyme chooses the correct chemical pathway at the quantum level.

The active site of the cytochrome P450 nanomachine gives rise to an inherent electrostatic landscape that serves as a hidden dimension governing the catalytic fate of the xenobiotic. This highly specific microenvironment controls charge transfer processes and also determines the thermodynamic stability of the highly reactive oxidants, most notably Compound I. Within this framework, local electric field (LEFs) function as dynamic energy landscapes shaped by the active site’s unique environment. They arise from the combined influence of charged residues, organized water networks, hydrogen bonding and transient structural shifts. These electrostatic fields reshape activation barriers, regulate charge distribution and selectively stabilize short-lived reactive intermediates while suppressing unwanted side processes. Consequently, catalytic efficiency in cytochrome P450 systems depends on not only on structural organization, but also on how the enzyme dynamically engineers its internal electrostatic environment.

In human cytochrome P450 systems, this electrostatic control is not only limited to the heme active site but extends upstream to the redox machinery that activates the entire P450 cycle. Wang et al., have demonstrated this principle in their recent investigation of the cytochrome P450 reductase (CPR), the essential electron donor responsible for dioxygen activation in microsomal P450s. Using molecular dynamics and hybrid QM/MM approaches, the study reveals that there is a proton-coupled electron transfer (PCET) between the FAD and FMN cofactors that enables electron transfer within CPR. More importantly, this process is heavily influenced by the electrostatic environment of the active site and not only cofactor proximity and protein dynamics.

The key residue from which the localized electric field is generated is the doubly protonated histidine H180 that influences the energetics of the PCET step. The positive charge on the imidazole side chain of H180 stabilizes the electron density change that accompanies the electron transfer and this leads to substantial reduction in the activation energy from 19.9 to 12.4 kcal/mol. This renders the PCET step both kinetically and thermodynamically feasible. Electrostatic interaction analysis further revealed that the positively charged HIP180 side chain preferentially stabilizes the transition and product states by 9.9 and 14.0 kcal/mol respectively, which is a substantially lower energetic cost of charge transfer and this enables the enzyme to guide the chemical reaction along a favorable pathway. In contrast, the removal of the electrostatic contribution from H180 destabilizes the charge transfer process, highlighting the central role of local electric fields in governing the electron-transfer process (Figure ).

15.

Electrostatic interaction energy between the positively charged HIP180 imidazole side chain and the reactant complexes across three states: IC2 (left), TS3 (middle) and IC3 (right). Labels indicate the stabilization energy provided by the HIP180 electric field, calculated as the difference in interaction energies between the intermediates and transition states. Note the transfer of the negative charge from FADH^– in IC2 to Glu142 in the IC3 state. Adapted from ref . Copyright 2024 American Chemical Society.

Altogether, these findings show that the electrostatic control in cytochrome P450 systems is directly linked to the enzyme’s larger dynamic architecture. Within the catalytic environment, structural plasticity, solvent organization, substrate confinement and transient charge distribution interact to produce local electric fields. As a result, catalytic activity emerges as an energy phenomenon across several spatial and temporal dimensions rather than being controlled by a single structural determinant.

3. Conclusion and Future Outlooks

The classical view of human cytochrome P450 enzymes as static, isolated biocatalysts has been progressively replaced by a dynamic, multiscale understanding of xenobiotic detoxification. The interaction of structural flexibility, xenobiotic trapping, solvent structure, and electrostatic regulation has led to the emergence of catalytic result as a systems-level feature. The perspective on xenobiotic detoxification has shifted from a confined chemical reaction to an emergent process distributed across several mechanistic layers, thanks to computational structure biology. Based on the recent advancements as discussed in earlier sections, we have synthesized a combined “thematic mechanism” starting from the substrate gating to xenobiotic metabolism in Figure . The process initiates with mechanosensitive dynamic gating, where flexible gating loops transition from a closed to an open state to permit xenobiotic entry. Upon its entry, the internal active site residues utilize their steric and electrostatic properties to force the xenobiotic into its final orientation within the catalytic site. This imposed geometry is then coupled to the allosteric water channel assembly, regulated by specific gating residues, priming the active site for proton delivery. The final catalytic strike is then further supported by the local electric fields (LEFs) of the enzyme driving necessary steps such as proton-coupled electron transfer (PCET) toward the confined xenobiotic.

16.

A representative schematic highlighting the four-dimensional lifetime of the xenobiotic within the CYP450 nanomachinery. (A) Dynamic Gating, where flexible loops show a closed conformation, preventing xenobiotic entry into the enzyme. (B) Substrate Positioning (C) Water Architecture where the ordered water channels are regulated via precise water-gating residues to connect the deeply buried xenobiotic to the bulk solvent for proton delivery. (D) Electrostatic Control (LEFs).

Despite these developments, creating completely predictive models of xenobiotic metabolism still presents significant obstacles. Transient conformational ensembles, fluctuating solvent networks and dynamically changing electrostatic landscapes that function across many spatial and temporal scales are the sources of the majority of the dynamic catalytic events discussed so far in this review. It is still computationally challenging to capture many interrelated events at the same time and it is still challenging to characterize short-lived reactive intermediates experimentally. However, using such structure–function insights discussed in the literature, we can tune CYP450 enzymes as mechanosensitive molecular machines using recent experimental techniques such as directed evolution and site-directed mutagenesis. Such insights from allosteric networks governing conformational gating, substrate-recognition pathways, transient water channel organization, and second-shell electrostatic environments could be helpful for future bioengineering in a directed way rather than relying on random empirical mutagenesis of catalytic residues.

However, while these aforementioned biophysical design rules provide the theoretical blueprint for engineering such biocatalysts, executing them on a vast, high-throughput scale remains a formidable challenge. Although microsecond molecular dynamics and hybrid QM/MM calculations have indeed brought the catalytic cycle of P450s to light, their computational cost limits large-scale predictive applications. Consequently, the next true inflection point in computational enzymology lies at the intersection of physics-based models and artificial intelligence (AI). Emerging machine-learning frameworks may eventually acquire mechanistic representations of dynamic catalytic action instead of only serving as statistical predictors. The integration of these techniques with emerging AI frameworks such as deep graph learning and foundational models offer a promising route to overcome these challenges. − Furthermore, recent advances are shifting the field from predicting sites of metabolism (SoB) toward identifying bonds of metabolism (BoM) leading to accurate, data-driven prediction of metabolites structures with reduced reliance on prior experimental knowledge. −

Cytochrome P450 systems is moving from being merely observed biological catalysts to programmable dynamic nanomachines whose reactivity, selectivity and toxicology outcomes can be logically predicted and ultimately engineered as computational enzymology continues to integrate molecular simulations, mechanistic quantum chemistry and artificial intelligence. − These approaches will eventually become essential to rational drug design, lowering late-stage clinical failures and safeguarding public health.

The authors declare no competing financial interest.

Published as part of ACS Bio & Med Chem Au special issue “2026 Rising Stars in Biological, Medicinal, and Pharmaceutical Chemistry”.